The grant process involves inviting specific scientists to respond to a request for applications (RFA). Once those materials are received they are reviewed by the Medical Advisory Board and the Board of Directors of the Inflammatory Breast Cancer Research Foundation.
Mark Dewhirst, DVM, PhD., received $50,000 to support the research into treatment for skin metastasis: “HIF-1 driven therapeutic resistance mechanisms in chest wall recurrences of inflammatory breast cancer (IBC).”
Dr. Dewhirst is the Gustavo S. Montana Professor of Radiation Oncology and Vice Director for Basic Science in the Duke Cancer Institute. Dr. Dewhirst has research interests in tumor hypoxia, angiogenesis, hyperthermia and drug transport.
This grant honors Kathleen Livingston, a strong research advocate who struggled with skin metastasis following her initial inflammatory breast cancer diagnosis until her death in 2011.